sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
µÍÑÛѹÇà¹âÑÛ¼²²¡¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÑۿƼ²²¡Ä£×Ó > µÍÑÛѹÇà¹âÑÛ¼²²¡¶¯ÎïÄ£×Ó

ǰÑÔ

µÍÑÛѹ¶ÔÑÛ×éÖ¯¿ÉÔì³ÉË𺦡£ºã¾ÃµÍÑÛѹ¿ÉÔì³ÉÊÓÈéÍ·Ë®Öס¢ÊÓÍøÄ¤³öѪ¡¢ÉøÍ¸¡¢»Æ°ßÐγɷÅÉä×´ÖåñÞ¡£ÊÓÈéÍ·ÊôÓÚÖÐÊàÉñ¾­µÄÒ»²¿·Ö£¬¶ø·ÇÖÜΧÉñ¾­×éÖ¯£¬ÓÌÈçÄÔ×éÖ¯¶ÔȱÑõ¡¢È±ÑªºÜÃô¸ÐÒ»Ñù£¬µÍÑÛѹʱ¼ä³¤£¬¿ÉÒýÆðÊÓÉñı»®Ñø´úлÕϰ­£¬±¬·¢²¡Àí¸Ä±ä¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î¼ÒÍÃ

¡¾ÔìÄ  £»úÖÆ¡¿£º

ÁÙ´²ÉÏÒýÆðµÍÑÛѹµÄÖ÷ÒªÔµ¹ÊÔ­ÓÉÊÇÑÛÍâÉË¡¢ÑÛÊÖÊõ¡¢ÑÛÄÚÑ×Ö¢µÈ¡£ÔÝʱÐÔµÍÑÛѹ£¬¿ÉÄÜÓÉÓÚ¾Ö²¿Ñª¹ÜÉñ¾­¹¦Ð§Ê§µ÷£¬»òÓÉÓÚëϸѪ¹ÜÄÚÆ¤ËðÉ˼°½Þ×´ÌåÉÏÆ¤ÊÜÀÛ£¬Ö·¿Ë®±¬·¢ïÔÌ­¡£ºã¾ÃÒ»Á¬ÐÔµÍÑÛѹ¿ÉÓÉÓÚ½Þ×´ÌåÍÑÀ룬ÖÂʹǰ·¿ºÍ½Þ×´ÌåÉÏǻǷºà£¬Ðγɷ¿Ë®ÅÔ·¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

¼ÒÍã¬ÌåÖØ1.5~3.0kg£¬Ë«ÑÛÑÛѹÕý³£¡£½«ÊµÑéÍõÄ1Ö»ÑÛΪʵÑéÑÛ£¬Áí1Ö»ÑÛΪ±ÈÕÕÑÛ¡£ÓÃ25£¥ÎÚÀ­Ì¹ÈÜÒºÓÚ¶ú¾²ÂöÂé×í£¬ÊµÑéÑÛµÎ0.5£¥µÄ¶¡¿¨ÒòÑÛÒº¾ÙÐÐÑÛ²¿±íÂ飬ȻºóÇгý2.0mm×3.0mmÉî²ã¹®Ä¤£¬¼Ó½Þ×´Ìå͸ÈÈÄý¹ÌÊõ£¬12µãÖÓ´¦×öºçĤ´ó²¿ÇгýÊõ¡£Êõºó¿¹Ñ×´¦Öóͷ££¬²¢ÊÓ²ì¼Í¼ÑÛ²¿ÇéÐΡ¢²âÑÛѹ¡£ÑÛѹʼÖÕÔÚ1.3kPa(10mmHg)ÒÔϵÄÍÃÑÛΪÔìÄ£Àֳɡ£

¡¾Ä£×ÓÌØµã¡¿£º

1.Õý³£±ÈÕÕÑÛÊÓÈéÍ·³¬Î¢½á¹¹ Ö÷ÒªÓÉ´ó×ÚÓÐËèÉñ¾­ÏËά¼°ÉÙÁ¿Éñ¾­½ºÖÊϸ°û×é³É£¬ÓÐËèÉñ¾­ÏËάµÄÍâ²ã¿É¼ûÅÅÁÐÕûÆëµÄ°å²ãËèÇÊ£¬ÖáË÷Äڿɼû´ó×Ú΢˿¼°Î¢¹Ü¡£

2.ʵÑéÑÛÊÓÈéÍ·³¬Î¢½á¹¹ ¢ÙµÍÑÛѹ7Ììʱ£¬´ó²¿·ÖÊÓÉñ¾­ÏËά½á¹¹»ù±¾Õý³££¬ÓÐÉÙÁ¿ÓÐËèÉñ¾­ÏËάÄڿɼûÇá¶È¿ÕÅÝ£¬Éñ¾­½ºÖÊϸ°ûÕý³£¡£¢ÚµÍÑÛѹ10Ììʱ£¬Éñ¾­ÏËάÖáË÷Äڴ󲿷ֿɼûÇá¶È¿ÕÅÝ£¬ÉÙÁ¿Éñ¾­ÏËάÕý³££¬Éñ¾­½ºÖÊϸ°ûÕý³£¡£¢ÛµÍÑÛѹ14Ììʱ£¬Éñ¾­ÏËάÖáË÷ÄÚÏÔ×Å¿ÕÅÝ»¯£¬¸öÌåËèÇʰå²ã¼äÊèÉ¢£¬ÐÇÐÎÉñ¾­½ºÖÊϸ°ûÄÚÏßÁ£ÌåÇá¶È¿ÕÅÝ»¯£¨Çá¶È²¡Àí¸Ä±ä£©¡£¢ÜµÍÑÛѹ21Ììʱ£¬Éñ¾­ÏËάÖáË÷ÄÚÑÏÖØ¿ÕÅÝ»¯£¬Î¢Ë¿¡¢Î¢¹ÜÏûÈÚ£¬ËèÇʰå²ãÊèÉ¢¼ÓÖØ£¬ÓеÄÉñ¾­ÏËά²¿·Ö·ºÆðÆÆË飬ÐÇÐÎÉñ¾­½ºÖÊϸ°ûÄÚÏßÁ£Ìå¿ÕÅÝ»¯£¬ºËÖܼä϶¼Ó¿í£¨ÏÔ×Ų¡Àí¸Ä±ä£©¡£¢ÝµÍÑÛѹ30Ììʱ£¬Éñ¾­ÏËάÖáË÷¼«¶Ë¿ÕÅÝ»¯£¬Î¢Ë¿¡¢Î¢¹ÜÏûÈÚ£¬ËèÇʰå²ã½á¹¹¶ÏÁÑ¡¢ÆÆË飬ÐÇÐÎÉñ¾­½ºÖÊϸ°û¼°ÉÙÍ»½ºÖÊϸ°ûÖ×ÕÍ£¬ÏßÁ£Ì弫¶Ë¿ÕÅÝ»¯£¬Ï¸°ûÄ¤ÆÆË飬ºËÖܼä϶ÏÔ×Å¼Ó¿í£¨ÑÏÖØ²»¿ÉÄæÐÔ²¡Àí¸Ä±ä£©¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

¸Ã·¨¼òÆÓÒ×ÐС£±ðµÄ£¬¼¤¹âÓÕ·¢ºÍα£­ÒÈÄýÈéÂѰ×øҲ¿ÉÓÕ·¢ÍõÄÇà¹âÑÛµÍÑÛѹģ×Ó¡£Ò²¿ÉÓÃÈçÏÂÒ©ÎïÖÆ×÷µÍÑÛѹ£ºÓÃ0.15£¥àçÂðÂå¶ûµãÑÛºó£¬ÑÛѹÏÔ×ÅϽµ£¬ÇÒºÍÑÛѹÐÄÀíÖÜÆÚÏà¹Ø  £»2£¥¶ÅÈûõ£°·ÒýÆðÑÛѹÏÔ×ÅϽµ£¬Ò¹¼äÒ²ÓкܺõĽµÑÛѹ×÷Óà  £»1£¥ÉöÉÏÏÙËØÊ¹ÑÛѹºã¾ÃϽµ£¬µ«¸±×÷ÓÃÏÔ×Å£¬ÒýÆð±ÕÑÛºÍÕ£ÑÛÔöÌí¡£¸ÃÄ£×ÓÊÊÓÃÓÚÑо¿µÍÑÛѹ¼²²¡µÄ±¬·¢Éú³¤¼°ÖÎÁÆ×ª¹é¡£

 

²Î¿¼ÎÄÏ×£º

1.ÂÀºì±ò£¬ÀîÑ࣬ԬԮÉú£¬µÈ£®ÖÆ×÷ÂýÐÔ¸ßÑÛѹ¶¯ÎïÄ£×ÓµÄÒ»ÖÖÐÂÒªÁ엗ˮϵçÄý¹®Ä¤Íâò¾²Âö·¨£®»ªÎ÷ҽѧ£¬2005,20 (4):699-700

2.ÀîάÄÈ£¬ËïÐË»³£®ÊµÑéÐÔµÍÑÛѹ¶¯ÎïÄ£×Ó£®ÑÛ¿ÆÑо¿£¬2004,22 (5):557-560

3.Ñîºê·½£¬ËïÐË»³£®½¨ÉèºïÇà¹âÑÛÄ£×ÓµÄÒªÁ죮ÖйúÑÛ¶ú±Çºí¿ÆÔÓÖ¾£¬2012, 12(5):327-329

4.Ê©ÐÂé࣬¹ËΪÍû£®ÈËÀ༲²¡¶¯ÎïÄ£×Ó£®±±¾©£ºÈËÃñÎÀÉú³öÊéÉ磬2008

5.κÐÀ£¬³ÂÏþÃ÷£¬ÙÜ´ºÑ࣬µÈ£®¾Û±½ÒÒϩ΢Çòǰ·¿×¢ÉäÓÕµ¼Ð¡Êó¸ßÑÛѹģ×Ó£®ÑÛ¿ÆÐÂÏ£Íû£¬2013,33 (3):204-209

6.Sappington RM,Ca..Ison BJ,Crish SD,el al. The Microbead Occlusion Model: a Paradigm for Induced Ocular Hypertension in Rats andÉÇce. Invest Ophthalrnol Vis Sci, 2010,51 (1):207-216

7.WoldeMussie E, Ruiz G, Wijono M,el al._Neuropmtection of retinal ganglion cells by brimonidine in rats with laser­ induced chronic ocular hypertension. lnvest Ophthalmol Vis Sci, 2001,42 (12):2849-2855

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÑۿƼ²²¡Ä£×Ó > µÍÑÛѹÇà¹âÑÛ¼²²¡¶¯ÎïÄ£×Ó
µÍÑÛѹÇà¹âÑÛ¼²²¡¶¯ÎïÄ£×Ó

ǰÑÔ

µÍÑÛѹ¶ÔÑÛ×éÖ¯¿ÉÔì³ÉË𺦡£ºã¾ÃµÍÑÛѹ¿ÉÔì³ÉÊÓÈéÍ·Ë®Öס¢ÊÓÍøÄ¤³öѪ¡¢ÉøÍ¸¡¢»Æ°ßÐγɷÅÉä×´ÖåñÞ¡£ÊÓÈéÍ·ÊôÓÚÖÐÊàÉñ¾­µÄÒ»²¿·Ö£¬¶ø·ÇÖÜΧÉñ¾­×éÖ¯£¬ÓÌÈçÄÔ×éÖ¯¶ÔȱÑõ¡¢È±ÑªºÜÃô¸ÐÒ»Ñù£¬µÍÑÛѹʱ¼ä³¤£¬¿ÉÒýÆðÊÓÉñı»®Ñø´úлÕϰ­£¬±¬·¢²¡Àí¸Ä±ä¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î¼ÒÍÃ

¡¾ÔìÄ  £»úÖÆ¡¿£º

ÁÙ´²ÉÏÒýÆðµÍÑÛѹµÄÖ÷ÒªÔµ¹ÊÔ­ÓÉÊÇÑÛÍâÉË¡¢ÑÛÊÖÊõ¡¢ÑÛÄÚÑ×Ö¢µÈ¡£ÔÝʱÐÔµÍÑÛѹ£¬¿ÉÄÜÓÉÓÚ¾Ö²¿Ñª¹ÜÉñ¾­¹¦Ð§Ê§µ÷£¬»òÓÉÓÚëϸѪ¹ÜÄÚÆ¤ËðÉ˼°½Þ×´ÌåÉÏÆ¤ÊÜÀÛ£¬Ö·¿Ë®±¬·¢ïÔÌ­¡£ºã¾ÃÒ»Á¬ÐÔµÍÑÛѹ¿ÉÓÉÓÚ½Þ×´ÌåÍÑÀ룬ÖÂʹǰ·¿ºÍ½Þ×´ÌåÉÏǻǷºà£¬Ðγɷ¿Ë®ÅÔ·¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

¼ÒÍã¬ÌåÖØ1.5~3.0kg£¬Ë«ÑÛÑÛѹÕý³£¡£½«ÊµÑéÍõÄ1Ö»ÑÛΪʵÑéÑÛ£¬Áí1Ö»ÑÛΪ±ÈÕÕÑÛ¡£ÓÃ25£¥ÎÚÀ­Ì¹ÈÜÒºÓÚ¶ú¾²ÂöÂé×í£¬ÊµÑéÑÛµÎ0.5£¥µÄ¶¡¿¨ÒòÑÛÒº¾ÙÐÐÑÛ²¿±íÂ飬ȻºóÇгý2.0mm×3.0mmÉî²ã¹®Ä¤£¬¼Ó½Þ×´Ìå͸ÈÈÄý¹ÌÊõ£¬12µãÖÓ´¦×öºçĤ´ó²¿ÇгýÊõ¡£Êõºó¿¹Ñ×´¦Öóͷ££¬²¢ÊÓ²ì¼Í¼ÑÛ²¿ÇéÐΡ¢²âÑÛѹ¡£ÑÛѹʼÖÕÔÚ1.3kPa(10mmHg)ÒÔϵÄÍÃÑÛΪÔìÄ£Àֳɡ£

¡¾Ä£×ÓÌØµã¡¿£º

1.Õý³£±ÈÕÕÑÛÊÓÈéÍ·³¬Î¢½á¹¹ Ö÷ÒªÓÉ´ó×ÚÓÐËèÉñ¾­ÏËά¼°ÉÙÁ¿Éñ¾­½ºÖÊϸ°û×é³É£¬ÓÐËèÉñ¾­ÏËάµÄÍâ²ã¿É¼ûÅÅÁÐÕûÆëµÄ°å²ãËèÇÊ£¬ÖáË÷Äڿɼû´ó×Ú΢˿¼°Î¢¹Ü¡£

2.ʵÑéÑÛÊÓÈéÍ·³¬Î¢½á¹¹ ¢ÙµÍÑÛѹ7Ììʱ£¬´ó²¿·ÖÊÓÉñ¾­ÏËά½á¹¹»ù±¾Õý³££¬ÓÐÉÙÁ¿ÓÐËèÉñ¾­ÏËάÄڿɼûÇá¶È¿ÕÅÝ£¬Éñ¾­½ºÖÊϸ°ûÕý³£¡£¢ÚµÍÑÛѹ10Ììʱ£¬Éñ¾­ÏËάÖáË÷Äڴ󲿷ֿɼûÇá¶È¿ÕÅÝ£¬ÉÙÁ¿Éñ¾­ÏËάÕý³££¬Éñ¾­½ºÖÊϸ°ûÕý³£¡£¢ÛµÍÑÛѹ14Ììʱ£¬Éñ¾­ÏËάÖáË÷ÄÚÏÔ×Å¿ÕÅÝ»¯£¬¸öÌåËèÇʰå²ã¼äÊèÉ¢£¬ÐÇÐÎÉñ¾­½ºÖÊϸ°ûÄÚÏßÁ£ÌåÇá¶È¿ÕÅÝ»¯£¨Çá¶È²¡Àí¸Ä±ä£©¡£¢ÜµÍÑÛѹ21Ììʱ£¬Éñ¾­ÏËάÖáË÷ÄÚÑÏÖØ¿ÕÅÝ»¯£¬Î¢Ë¿¡¢Î¢¹ÜÏûÈÚ£¬ËèÇʰå²ãÊèÉ¢¼ÓÖØ£¬ÓеÄÉñ¾­ÏËά²¿·Ö·ºÆðÆÆË飬ÐÇÐÎÉñ¾­½ºÖÊϸ°ûÄÚÏßÁ£Ìå¿ÕÅÝ»¯£¬ºËÖܼä϶¼Ó¿í£¨ÏÔ×Ų¡Àí¸Ä±ä£©¡£¢ÝµÍÑÛѹ30Ììʱ£¬Éñ¾­ÏËάÖáË÷¼«¶Ë¿ÕÅÝ»¯£¬Î¢Ë¿¡¢Î¢¹ÜÏûÈÚ£¬ËèÇʰå²ã½á¹¹¶ÏÁÑ¡¢ÆÆË飬ÐÇÐÎÉñ¾­½ºÖÊϸ°û¼°ÉÙÍ»½ºÖÊϸ°ûÖ×ÕÍ£¬ÏßÁ£Ì弫¶Ë¿ÕÅÝ»¯£¬Ï¸°ûÄ¤ÆÆË飬ºËÖܼä϶ÏÔ×Å¼Ó¿í£¨ÑÏÖØ²»¿ÉÄæÐÔ²¡Àí¸Ä±ä£©¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

¸Ã·¨¼òÆÓÒ×ÐС£±ðµÄ£¬¼¤¹âÓÕ·¢ºÍα£­ÒÈÄýÈéÂѰ×øҲ¿ÉÓÕ·¢ÍõÄÇà¹âÑÛµÍÑÛѹģ×Ó¡£Ò²¿ÉÓÃÈçÏÂÒ©ÎïÖÆ×÷µÍÑÛѹ£ºÓÃ0.15£¥àçÂðÂå¶ûµãÑÛºó£¬ÑÛѹÏÔ×ÅϽµ£¬ÇÒºÍÑÛѹÐÄÀíÖÜÆÚÏà¹Ø  £»2£¥¶ÅÈûõ£°·ÒýÆðÑÛѹÏÔ×ÅϽµ£¬Ò¹¼äÒ²ÓкܺõĽµÑÛѹ×÷Óà  £»1£¥ÉöÉÏÏÙËØÊ¹ÑÛѹºã¾ÃϽµ£¬µ«¸±×÷ÓÃÏÔ×Å£¬ÒýÆð±ÕÑÛºÍÕ£ÑÛÔöÌí¡£¸ÃÄ£×ÓÊÊÓÃÓÚÑо¿µÍÑÛѹ¼²²¡µÄ±¬·¢Éú³¤¼°ÖÎÁÆ×ª¹é¡£

 

²Î¿¼ÎÄÏ×£º

1.ÂÀºì±ò£¬ÀîÑ࣬ԬԮÉú£¬µÈ£®ÖÆ×÷ÂýÐÔ¸ßÑÛѹ¶¯ÎïÄ£×ÓµÄÒ»ÖÖÐÂÒªÁ엗ˮϵçÄý¹®Ä¤Íâò¾²Âö·¨£®»ªÎ÷ҽѧ£¬2005,20 (4):699-700

2.ÀîάÄÈ£¬ËïÐË»³£®ÊµÑéÐÔµÍÑÛѹ¶¯ÎïÄ£×Ó£®ÑÛ¿ÆÑо¿£¬2004,22 (5):557-560

3.Ñîºê·½£¬ËïÐË»³£®½¨ÉèºïÇà¹âÑÛÄ£×ÓµÄÒªÁ죮ÖйúÑÛ¶ú±Çºí¿ÆÔÓÖ¾£¬2012, 12(5):327-329

4.Ê©ÐÂé࣬¹ËΪÍû£®ÈËÀ༲²¡¶¯ÎïÄ£×Ó£®±±¾©£ºÈËÃñÎÀÉú³öÊéÉ磬2008

5.κÐÀ£¬³ÂÏþÃ÷£¬ÙÜ´ºÑ࣬µÈ£®¾Û±½ÒÒϩ΢Çòǰ·¿×¢ÉäÓÕµ¼Ð¡Êó¸ßÑÛѹģ×Ó£®ÑÛ¿ÆÐÂÏ£Íû£¬2013,33 (3):204-209

6.Sappington RM,Ca..Ison BJ,Crish SD,el al. The Microbead Occlusion Model: a Paradigm for Induced Ocular Hypertension in Rats andÉÇce. Invest Ophthalrnol Vis Sci, 2010,51 (1):207-216

7.WoldeMussie E, Ruiz G, Wijono M,el al._Neuropmtection of retinal ganglion cells by brimonidine in rats with laser­ induced chronic ocular hypertension. lnvest Ophthalmol Vis Sci, 2001,42 (12):2849-2855

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿